Overview of Диклофен

Quick Facts

Property	Description
Active ingredient	Diclofenac (Sodium, Potassium, or Diethylamine salt)
Pharmacological class	Nonsteroidal Anti-Inflammatory Drug (NSAID)
Chemical class	Phenylacetic acid derivative
Primary Forms	Oral tablets, injections, topical gels/patches
Origin	Synthetic
General Purpose	Relief of pain, inflammation, and fever

Диклофен: Definition and Pharmacological Classification

Диклофен is a well-established, synthetic medicinal product containing the active substance Diclofenac. Pharmacologically, it is defined as a quintessential Nonsteroidal Anti-Inflammatory Drug (NSAID).

The chemical structure of Diclofenac classifies it as a derivative of Phenylacetic acid, a unique foundation that distinguishes its profile within the broad NSAID group. It is commonly supplied as a salt, such as Diclofenac Sodium or Diclofenac Potassium, the latter often formulated for faster dissolution compared to the sodium variant. This strategic formulation ensures timely therapeutic action, which is clinically recognized for its effectiveness in rapidly addressing acute inflammatory pain.

Forms, Origin, and General Therapeutic Purpose

Diclofenac is available in a variety of pharmaceutical preparations, enabling both systemic administration via forms like oral tablets and solutions for injection, and local application via topical gels or transdermal patches. Its overall general purpose is to reduce pain and minimize the effects of inflammation. Diclofenac is used as therapy for acute and chronic pain and inflammation arising from diverse causes, which underscores its broad applicability.

This drug achieves its general therapeutic effect by limiting the production of key chemical mediators in the body. The fundamental mechanism provides three core benefits: anti-inflammatory activity, analgesic activity, and antipyretic activity. The availability of multiple administration routes ensures that the Diclofenac substance can be matched to the patient's specific need for either broad internal relief or targeted external action.

What side effects are possible with Диклофен?

Possible Side Effects and Safety Information

Diclofenac is associated with significant safety concerns and carries regulatory warnings regarding the potential for serious adverse events. Use of the drug, particularly at higher doses and for long-term treatment, increases these risks.

Serious Adverse Reactions

Cardiovascular (CV) Thrombotic Events: Nonsteroidal Anti-inflammatory Drugs (NSAIDs) such as diclofenac may increase the risk of serious CV thrombotic events, including myocardial infarction (heart attack) and stroke, which can be fatal. This risk may begin early in treatment and is considered to increase with dose and duration of use. Diclofenac is contraindicated for the treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery.
Gastrointestinal (GI) Events: NSAIDs carry an increased risk of serious GI adverse events, including inflammation, bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These serious events can occur without warning symptoms. Elderly patients and those with a prior history of GI disease are at greater risk.

Key Adverse Reaction Categories

Common adverse reactions typically involve the gastrointestinal system (e.g., dyspepsia, abdominal pain, nausea) and nervous system (e.g., headache, dizziness). Other documented side effects affect the Hepatobiliary system (liver), potentially leading to hepatotoxicity; the Renal system, with risks for renal papillary necrosis and other injury; and the Skin, where serious reactions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) have been reported.

Safety Restrictions and Monitoring

Diclofenac is contraindicated in patients with established congestive heart failure (NYHA class II-IV), ischaemic heart disease, peripheral arterial disease, or cerebrovascular disease. It is also contraindicated in patients with a history of aspirin-sensitive asthma or active GI ulceration/bleeding. To minimize potential risks, the lowest effective dose for the shortest possible duration should be used. Patients should be monitored for signs of hypertension, fluid retention, or worsening liver/kidney function during treatment.

Overdose and Emergency Response

Overdose and when to seek help

Official regulatory documentation states that Diclofenac overdose can lead to multi-system toxicity, with severe manifestations often affecting the gastrointestinal, neurological, and cardiovascular systems.

Documented Overdose Presentations

System	Documented Manifestations
Gastrointestinal	Bleeding, ulceration, or perforation.
Neurological	Convulsions (seizures), confusion, or coma.
Hepatic / Renal	Elevated liver enzymes; acute renal injury or decompensation.

Required Emergency Actions

Condition	Action Mandated by Labeling
Suspected Overdose	Treatment is symptomatic and supportive only; no specific antidote is known is documented.
Life-Threatening Symptoms	Seek immediate medical attention or contact emergency services for signs of a serious thrombotic event (e.g., chest pain, slurred speech) or severe gastrointestinal bleeding.

Official guidance notes that elderly patients and those with pre-existing renal or hepatic impairment are at a greater risk for severe or fatal outcomes following acute exposure. Management often requires continuous monitoring of renal function and fluid balance. If acute overexposure is suspected, procedures to prevent further drug absorption, such as gastric lavage, may be initiated as part of supportive care.

Therapeutic Uses of Диклофен

What Диклофен Treats: Main Uses and Benefits

Диклофен is commonly used across key therapeutic areas where symptoms related to inflammatory or irritative states and physical discomfort are the primary concern. It plays a role in managing symptoms in conditions such as osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. The therapeutic role is relevant for managing symptoms in these conditions. It provides supportive therapeutic benefit by helping to moderate these challenging symptoms.

Symptomatic Support and Benefit

Диклофен is commonly used in conditions characterized by periods of heightened symptoms, including chronic inflammatory joint diseases, acute pain from soft tissue injuries, and episodic pain syndromes like migraine, gout, and primary dysmenorrhea. It helps address symptom clusters that may appear suddenly or intensify over time, providing support that helps ease the overall symptom burden.

“It is commonly used when short-term symptomatic assistance is needed following acute episodes or during flare-ups of chronic discomfort.”

The therapeutic benefit is associated with managing joint pain, swelling, and stiffness. It assists with maintaining functional stability and contributes to improved day-to-day comfort during periods of heightened symptoms.

Quick Fact: Relief for Pain
Primary Symptom Focus	Pain, Inflammation, and Stiffness
Typical Use Context	Acute injury, Chronic joint management, Episodic pain flares
Key Benefit	Eases symptom burden and supports comfort

Acute and Episodic Use

The medication may be applied during phases of increased distress or discomfort. This includes managing pain and inflammation from minor strains, sprains, and contusions, as well as addressing the intense, recurrent manifestations of conditions like gout and menstrual cramps. It is relevant when symptoms become temporarily overwhelming, offering symptomatic relief that helps patients cope more steadily with difficult episodes.

Eligibility and Restrictions for Use

Eligibility and Contraindications for Diclofenac

Diclofenac is generally for use by adults, though specific topical formulations may be indicated for pediatric patients as young as 6 or 12 years of age, depending on the product. Use is primarily restricted or prohibited in patients with certain pre-existing health conditions or physiological states, based on official regulatory labeling.

Contraindicated Groups (Do NOT Use)	Restricted/Special Consideration
Known hypersensitivity (allergy) to diclofenac or any ingredient.	Patients with severe heart failure or advanced renal disease.
History of asthma, hives, or allergic-type reactions after taking aspirin or other NSAIDs (Aspirin-sensitive asthma).	Patients with a recent heart attack (MI).
For pain treatment during and right after Coronary Artery Bypass Graft (CABG) surgery.	Patients with uncorrected dehydration or hypovolemia.
Pregnancy at 30 weeks gestation and later.	Use should be avoided or limited in women between 20 and 30 weeks gestation.

Older adult patients (geriatric population) should use diclofenac with caution, as they are at higher risk for serious gastrointestinal and cardiovascular events. The cardiovascular risks, including the potential for heart attack or stroke, may increase with higher doses and longer duration of treatment. The decision to use diclofenac during lactation should be made cautiously after weighing the minimal risk of excretion into breast milk against the potential maternal benefits. Patients with established heart failure, ischemic heart disease, or cerebrovascular disease are generally advised against using diclofenac.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Diclofenac (Диклофен) is officially documented by regulatory agencies and is primarily characterized by the risk of additive toxicity and alterations in systemic exposure.

Documented Interaction Constraints

Interaction Type	Interacting Substances/Classes
Contraindicated Combinations	Other systemic Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), including COX-2 selective inhibitors, and antiplatelet doses of Aspirin (increased GI risk).
Exposure-Altering	Potent CYP2C9 Inhibitors (e.g., Voriconazole) may increase Diclofenac plasma concentration. Diclofenac increases plasma levels of Lithium and Methotrexate by reducing their clearance.
Pharmacodynamic Risk	Anticoagulants (e.g., Warfarin) and SSRIs (increased bleeding risk); Diuretics, ACE Inhibitors, and ARBs (reduced antihypertensive effect and increased risk of renal impairment).

Co-administration with alcohol increases the documented risk of gastrointestinal bleeding. For oral formulations, taking the medicine with food may reduce the rate and extent of its absorption. Interactions that impair renal function are considered more clinically significant in elderly patients due to potential baseline reduced renal function. The documented constraints mandate careful consideration, especially for combinations affecting coagulation or renal function.

Mechanism of Action

How Диклофен Works

Диклофен, through its active substance Diclofenac, operates by influencing enzyme-mediated biochemical signaling, primarily as a non-selective, reversible inhibitor of the Cyclooxygenase ( COX) enzymes ( COX-1 and COX-2).

This targeted molecular blockade prevents the conversion of Arachidonic Acid into prostaglandins ( PGE2, PGI2) and other eicosanoids, thereby decreasing the concentration of pro-inflammatory eicosanoids within the system. The reduction in PGE2 levels leads to two primary physiological adjustments:

Peripheral: Reduced chemical sensitization of nociceptors (pain sensors), reducing the effect of local chemical mediators.
Central: Suppression of PGE2 synthesis in the hypothalamus, allowing the thermoregulatory set point to decrease within the central pathway.

Diclofenac's activity is intrinsically linked to biological processes driven by prostaglandins and is less relevant in pathways dominated by non-eicosanoid chemical mediators.

Dosage and Administration Information

Диклофен (Diclofenac) is administered via multiple routes, including oral (tablets, capsules, powder for solution), topical (gels, patches), rectal (suppositories), and parenteral (Intramuscular injection or Intravenous infusion). These varied administration methods enable delivery for either localized application or systemic absorption.

A general principle for systemic therapy involves utilizing the lowest effective dose for the shortest duration possible. For many common oral delayed-release regimens, the total daily dose generally does not exceed 150 mg. Oral formulations are typically scheduled as once daily for extended-release forms or in two to four divided doses daily for immediate-release preparations.

Specific administration constraints govern its use. Certain oral forms, such as delayed- or extended-release tablets, must be swallowed whole and cannot be crushed or split to preserve their intended release characteristics. Similarly, the oral powder formulation for acute use is specified to be mixed with water and taken on an empty stomach.

Duration of use is also determined by the administration route. Parenteral administration via injection or infusion is designated for short-term use only, with systemic use limited to a maximum of two consecutive days, after which treatment may transition to oral or rectal forms if needed.

High-Level Administration Rules	Standard Requirement
Form Integrity	Tablets must be swallowed whole; not split or crushed.
Parenteral Limit	Use of IM or IV injection must not exceed two consecutive days.
Dosing Constraint	The total daily dose across all systemic forms must not exceed the specified maximum.

Recent Clinical Evidence

Evidence for use in Chronic Inflammatory Joint Conditions

Research in conditions like Osteoarthritis (OA) and Rheumatoid Arthritis (RA) utilized Randomized Controlled Trials (RCTs) and Systematic Reviews. These studies examined patient-reported outcomes related to physical discomfort and functional imbalance in adult and older adult populations. Findings describe patterns observed where measurements of pain scores and function scores research highlights changes measured during the study period. However, evidence quality varies across studies, and long-term effects are not fully established by controlled trials extending beyond one year.

Evidence for use in Localized and Acute Pain States

For localized pain and acute episodes, Diclofenac was evaluated in numerous short-term, placebo-controlled RCTs for conditions such as acute musculoskeletal injuries and episodic pain syndromes. Research highlights changes measured during the study period related to daily functioning or activity level and changes in patient-reported discomfort specifically at the site of application for topical forms. Follow-up durations were typically limited to a few weeks, meaning results apply only to the specific populations and short time intervals over which they were monitored.

Long-term Studies and Durability of Findings

Research exploring the long-term context has utilized observational settings evaluating daily-life functioning and continued use patterns. This evidence contributes to understanding symptom patterns over extended use. Despite this, limited information for long-term outcomes is available from RCTs for newer formulations, and comparative evidence is lacking when considering long-term use versus other therapeutic options.

Evidence in Special Populations

Research on Diclofenac focused on studies that included older adult populations managing chronic conditions characterized by fluctuating manifestations. While findings describe patterns observed in these groups, data for groups defined by severe or numerous co-existing medical conditions remain insufficient, and limited information is available for highly complex populations.

What Is Still Uncertain About Диклофен Research

One key limitation is that evidence quality varies across studies, with findings mixed regarding the consistency of findings across different patient types. While studies have thoroughly examined outcomes in established conditions, data are still emerging for certain specific formulations and for use in deeper joints, such as the spine. Consequently, evidence for certain groups is limited, and certainty remains low on the full range of long-term patterns outside of the well-studied chronic inflammatory conditions.

Frequently Asked Questions (FAQ)

Common questions about Диклофен (FAQ)

Q: Does Диклофен cause sleepiness or drowsiness?

Official product information states that central nervous system effects are possible. These commonly include dizziness, headache, and drowsiness (sometimes called somnolence). Regulatory warnings typically recommend caution when these effects are present.

Q: Is Диклофен safe for people with high blood pressure?

Official warnings note that the use of Диклофен warrants caution in patients with high blood pressure (hypertension). This is because the medication is known to cause fluid retention, which can potentially worsen blood pressure. Regulatory documents state that monitoring of blood pressure is warranted during treatment.

Q: What are the most common reasons someone might stop taking Диклофен?

Based on clinical data, the most commonly reported adverse effects that result in patients stopping the medication involve the gastrointestinal system. These issues often include abdominal pain, nausea, and dyspepsia (indigestion). Increases in liver enzyme levels are also noted as a reason for discontinuation in official reporting.

Q: Can women who are planning pregnancy use Диклофен?

Regulatory documents caution that Диклофен may impair female fertility. For this reason, its use is generally not recommended for women who are actively attempting to conceive. Official information indicates that if a patient is experiencing difficulty becoming pregnant, discontinuation of the medication is a factor for consideration.

Q: What are the rules for driving or operating machinery while on Диклофен?

Official patient information states that driving or operating machinery is not recommended if certain side effects are experienced. These specific effects include visual disturbances, dizziness, or somnolence (drowsiness).

Q: What age group is Диклофен generally not recommended for?

Oral tablet forms of Диклофен are generally not recommended for use in children aged 14 years and below. However, official labeling for specific topical products, such as gels or patches, may indicate use for younger pediatric age groups. This rule varies by the exact formulation.

Q: Does Диклофен have a black box warning in the US or similar caution in Europe?

In the United States, official product labeling includes a prominent Boxed Warning. This warning highlights the risk of serious cardiovascular thrombotic events, such as heart attack and stroke, and the risk of serious gastrointestinal adverse events, including bleeding, ulceration, and perforation.

Q: Does Диклофен interact with commonly used anxiety medications?

Regulatory documents state that Диклофен interacts with a class of medicines known as Selective Serotonin Reuptake Inhibitors (SSRIs), which are commonly used for anxiety and depression. This specific interaction is documented because the combination can potentially lead to an increased risk of bleeding.

Q: Can I use Диклофен if I have asthma?

Диклофен is strictly contraindicated (should not be used) if a patient has a history of aspirin-sensitive asthma. For patients with asthma that is not sensitive to aspirin, official warnings note that caution is warranted during use, as NSAID medicines have the potential to precipitate bronchospasm (a sudden tightening of the airways).

Q: How long does it usually take for Диклофен to start working for pain?

Based on clinical pharmacology reviews, the onset of meaningful pain relief for some oral formulations can be relatively quick. Studies indicate that for responder patients, the onset of this effect may occur around 30 minutes after administration.

Q: What is the expected duration of the pain relief from Диклофен?

The analgesic effect is generally expected to last for a certain period following a single dose. Official data indicates that this pain-relieving effect typically lasts for approximately 4 to 6 hours.

Q: Do I need a prescription to get Диклофен?

The required classification of Диклофен (prescription vs. non-prescription) varies based on the country, the dose, and the specific product form. Generally, low-dose forms intended for short-term use may be available over-the-counter, while higher doses and injectable products typically require a prescription.

Q: Is Диклофен known to interact with commonly used cold medicines?

Official interaction constraints specify that combining Диклофен with other Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is not recommended. Because many common cold and flu medicines contain other NSAIDs, this combination is contraindicated due to an increased risk of gastrointestinal side effects.

Q: What should I do if I forget to take a dose of Диклофен?

Patient information leaflets provide guidance for handling a forgotten dose. If a regular dose is missed and it is almost time for the next scheduled dose, the regulatory advice is to skip the missed one. The guidance specifies that taking a double dose to compensate for a missed dose is not advised.

Q: What is the general safety classification of Диклофен according to health authorities?

According to official health authority safety data sheets, the active substance has specific regulatory classifications. These include being categorized as an acute toxicity substance (Harmful if swallowed) and a substance with the potential for specific target organ toxicity through prolonged or repeated exposure.

Q: Is there any evidence that Диклофен can help with migraines?

Specific formulations of Диклофен have received official approval and are clinically indicated for the acute treatment of migraine attacks. This indication includes use for both migraines with and without aura.

Q: What is the main reason Диклофен is restricted in certain countries?

Regulatory reviews and restrictions implemented by some health authorities are primarily based on the drug's specific risk profile. This is mainly due to an elevated risk for serious cardiovascular thrombotic events (such as heart attack and stroke) compared to the risks associated with some other traditional NSAID medicines.

Q: What does 'contraindication' mean regarding Диклофен use?

In medical terms, a contraindication refers to any condition, symptom, or circumstance that renders a specific treatment inadvisable. For Диклофен, this means that if a patient has a contraindication (such as severe heart failure or active ulceration), using the medication is officially prohibited.

Q: How long after stopping Диклофен does it clear out of the body?

Pharmacological data indicates how quickly the active substance is eliminated from the body by citing its half-life. The terminal half-life of unchanged diclofenac is relatively short, approximately 1 hour.

How should Диклофен be stored and disposed of?

Official Storage and Disposal Requirements

Storage Conditions and Protection

Diclofenac formulations must be stored at controlled room temperature (e.g., 20 C to 25 C), away from excessive heat, moisture, and direct light. The medication must be kept in its original, tightly closed container and explicitly kept from freezing to maintain product stability.

Requirement	Official Instruction
Temperature	Controlled room temperature (20 C to 25 C)
Protection	Protect from heat, light, moisture, and do not freeze
Container Rule	Keep in original, tightly closed container

Handling and Disposal

All forms of Diclofenac must be stored out of the reach of children and pets. Official labeling for the highly potent topical patch requires that the used patch be folded in half (adhesive sides together) immediately after removal and disposed of securely out of children's reach to prevent accidental exposure.

Patients should ask a healthcare professional or pharmacist for instructions on how to dispose of unused or expired medicine and should generally not flush the product down the toilet.

Диклофен